Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
39.22
+0.48 (1.24%)
Apr 24, 2026, 11:34 AM HKT

HKG:3692 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15,02812,26110,1049,3829,935
Revenue Growth (YoY)
22.57%21.35%7.69%-5.56%14.32%
Cost of Revenue
1,5191,1171,033870.19870.39
Gross Profit
13,50911,1449,0718,5129,065
Selling, General & Admin
4,7364,5084,2414,1484,371
Research & Development
3,3582,7022,0971,6931,797
Other Operating Expenses
15.1331.9853.963.7375.91
Operating Expenses
8,1087,2426,3925,9056,244
Operating Income
5,4013,9022,6792,6072,821
Interest Expense
-3.16-6.69-66.68-58.14-52.82
Interest & Investment Income
1,0981,0461,020331.52253.85
Earnings From Equity Investments
---2.12-13.86-
Currency Exchange Gain (Loss)
-44.0621.434.5744.56-9.31
Other Non Operating Income (Expenses)
111.0887.35105.25117.17139.34
EBT Excluding Unusual Items
6,5635,0503,7413,0293,152
Gain (Loss) on Sale of Investments
-16.7161.27158.2267.58144.49
Gain (Loss) on Sale of Assets
4.35.722.111.243.94
Asset Writedown
--31.98---
Other Unusual Items
---134.71-159.12-
Pretax Income
6,5515,0853,7662,9483,300
Income Tax Expense
995.12713.36488.65364.68587.18
Net Income
5,5554,3723,2782,5842,713
Net Income to Common
5,5554,3723,2782,5842,713
Net Income Growth
27.07%33.39%26.85%-4.76%5.61%
Shares Outstanding (Basic)
5,9635,9305,9255,9165,921
Shares Outstanding (Diluted)
5,9815,9506,0205,9295,998
Shares Change (YoY)
0.52%-1.16%1.52%-1.14%2.04%
EPS (Basic)
0.930.740.550.440.46
EPS (Diluted)
0.930.730.520.440.44
EPS Growth
26.42%40.62%19.65%-1.29%1.21%
Free Cash Flow
-3,6402,8972,4682,117
Free Cash Flow Per Share
-0.610.480.420.35
Dividend Per Share
0.3880.3160.1930.0880.073
Dividend Growth
22.73%63.53%118.47%20.84%12.44%
Gross Margin
89.89%90.89%89.78%90.72%91.24%
Operating Margin
35.94%31.83%26.52%27.79%28.39%
Profit Margin
36.97%35.66%32.44%27.54%27.31%
Free Cash Flow Margin
-29.69%28.67%26.31%21.31%
EBITDA
5,7774,2783,0252,9323,084
EBITDA Margin
38.44%34.89%29.94%31.25%31.04%
D&A For EBITDA
375.57375.57345.63324.37263.42
EBIT
5,4013,9022,6792,6072,821
EBIT Margin
35.94%31.83%26.52%27.79%28.39%
Effective Tax Rate
15.19%14.03%12.97%12.37%17.79%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.